TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07101809: Trial of Ureteroscopy vs Steerable Continuous Flow Aspiration Technology

Sponsor: Calyxo, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 150 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$7,038,400

Rescue Site Savings

+$4,648,000

Unlock Full NCT07101809 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07101809 Rescue Dossier →